Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies Licenses IP to EraGen

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genetic Technologies today said that it has signed a settlement and licensing agreement with EraGen Biosciences covering its non-coding patents.

It is the second such licensing deal that Genetic Technologies has signed this week for the intellectual property. On Monday, it had announced that it settled a legal dispute with Gen-Probe over the technology, which resulted in Gen-Probe taking a license.

Gen-Probe was one of several parties named in a suit filed by Genetic Technologies in February. The Australian firm has asserted that the firms named in the suit were infringing a US patent covering methods of analyzing non-coding DNA sequences. Among the firms named in the suit were Gen-Probe, Beckman Coulter, Orchid Cellmark, Interleukin Genetics, Molecular Pathology Laboratory Network, PIC USA, Pioneer Hi-Bred International, and Sunrise Medical Laboratories.

EraGen was not named in the suit, but Genetic Technologies said today that the firms have been engaged in discussions regarding the patents "for some time."

Financial and other terms of the license have not been disclosed by the companies.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.